DOSTARLIMAB
dostarlimab 500 mg/10 mL injection, 10 mL vial
DOSTARLIMAB (14130Q)
14130Q
Manner of administration:Injection
Restriction (Streamlined authority code: 15205)
Indication: Advanced, metastatic or recurrent endometrial carcinoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1000 mg | # of repeats: 3 | DPMA: $15,386.23 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Jemperli
(dostarlimab 500 mg/10 mL injection, 10 mL vial)
|
||||
